Isoprenaline Hcl Macure

Isoprenaline Hydrochloride, the active ingredient in Isoprenaline Hcl Macure, is a non‑selective beta‑adrenergic agonist presented as an injectable solution for intravenous use. It is employed to raise heart rate and contractility in bradycardia and heart block, and to produce bronchodilation in asthma or bronchospasm.

GNH USA supplies Isoprenaline Hcl Macure as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with sourcing from the European Union market, ensuring quality and regulatory compliance through rigorous testing and validated manufacturing processes.

Isoprenaline Hydrochloride is a beta‑adrenergic agonist used in cardiovascular and respiratory conditions. - Bradycardia: increases heart rate to restore adequate cardiac output. - Heart block: enhances atrioventricular conduction to improve rhythm stability. - Asthma: relaxes bronchial smooth muscle to relieve airway obstruction. - Bronchospasm: induces bronchodilation for rapid relief of acute bronchospastic episodes.

Isoprenaline may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tachycardia: rapid increase in heart rate. - Palpitations: sensation of irregular or forceful heartbeats. - Headache: mild to moderate cranial pain. - Tremor: fine muscle shaking, especially in the hands. - Nausea: upset stomach or urge to vomit. - Anxiety: feelings of nervousness or restlessness.

Serious or Rare Side Effects: - Arrhythmias: potentially life‑threatening irregular heart rhythms. - Myocardial ischemia: reduced blood flow to heart muscle causing chest pain. - Severe hypotension: marked drop in blood pressure leading to dizziness. - Pulmonary edema: fluid accumulation in lungs impairing breathing. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Paradoxical bronchospasm: unexpected tightening of airway muscles.

When using Isoprenaline, several safety measures should be observed to minimize risks. - Monitor cardiac rhythm: continuous ECG monitoring is recommended during infusion. - Avoid in severe tachyarrhythmia: may exacerbate rapid heart rhythms. - Use cautiously in hypertension: can further elevate blood pressure. - Adjust dose in renal or hepatic impairment: impaired clearance may increase effects. - Observe glucose levels in diabetics: β‑agonists can affect blood sugar. - Contraindicated in pheochromocytoma: risk of hypertensive crisis. - Store at ambient temperature: keep in original container, protect from light and moisture.

Isoprenaline can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta‑blockers: antagonize therapeutic effects and may precipitate severe bradycardia. - Class I antiarrhythmics (e.g., quinidine): increase risk of pro‑arrhythmic events. - Tricyclic antidepressants: may potentiate cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: additive effects on heart rate and contractility require monitoring. - Diuretics: electrolyte disturbances can modify response to β‑agonist therapy. - Theophylline: combined use may heighten tachycardia and tremor.